Papers: 10.3390/cells10051052
https://doi.org/10.3390/cells10051052
Remdesivir and Ledipasvir among the FDA-Approved Antiviral Drugs Have Potential to Inhibit SARS-CoV-2 Replication
Cited by: 24
Author(s): Rameez Hassan Pirzada, Muhammad Haseeb, Maria Batool, MoonSuk Kim, Sangdun Choi
Published: about 4 years ago
Software Mentions 2
Very Likely Science (75)
pypi: PyMOL
Papers that mentioned: 8,266
Very Likely Science (90)